Literature DB >> 1597198

Cross-reactive proteins of Borrelia burgdorferi.

H R Bruckbauer1, V Preac-Mursic, R Fuchs, B Wilske.   

Abstract

The specificity of serological tests for Lyme borreliosis is impaired by cross-reacting antibodies. In order to select antigens for more specific tests, specific and cross-reactive proteins of Borrelia burgdorferi must be identified. Therefore, to analyze cross reactions of Borrelia burgdorferi with other bacteria, rabbit immune sera against heterologous bacteria (Borrelia hermsii, Treponema pallidum, Treponema phagedenis, Leptospira interrogans (serogroup grippotyphosa), Neisseria meningitidis, Haemophilus influenzae, Yersinia enterocolitica (serotypes O3 and O9), Campylobacter jejuni, Listeria monocytogenes O1, Pseudomonas aeruginosa, Escherichia coli, Salmonella typhimurium, Shigella flexneri and Legionella micdadei) were examined by Western blot using Borrelia burgdorferi as antigen. Broad cross reactivity was shown for Borrelia proteins of the 60-75 kDa range. Other broadly cross-reacting proteins were at the level of p40, p33 and two proteins in the range of 20 kDa. Some of the cross reactions were eliminated by absorption of the sera with Treponema phagedenis. The absorbed antibodies were directed mainly against bands at the level of p33 and bands of the 60 to 75 kDa range. Showing the lowest potential for cross reactivity, p100, p41, OspA and pC seem to be the most suitable antigens for serodiagnosis. In contrast to p100 and OspA, however, p41 and pC showed cross reactivity with immune sera against bacteria not belonging to the genus Borrelia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597198     DOI: 10.1007/bf02098084

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  The Borrelia burgdorferi flagellum-associated 41-kilodalton antigen (flagellin): molecular cloning, expression, and amplification of the gene.

Authors:  R Wallich; S E Moter; M M Simon; K Ebnet; A Heiberger; M D Kramer
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Thermoregulation of protein synthesis in Borrelia burgdorferi.

Authors:  R G Cluss; J T Boothby
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  Antigenic variability of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; G Schierz; R Kühbeck; A G Barbour; M Kramer
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Related vibrio in stools.

Authors:  J P Butzler; P Dekeyser; M Detrain; F Dehaen
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

Review 5.  Laboratory aspects of Lyme borreliosis.

Authors:  A G Barbour
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

7.  Serological diagnosis of erythema migrans disease and related disorders.

Authors:  B Wilske; G Schierz; V Preac-Mursic; K Weber; H W Pfister; K Einhäupl
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

Review 8.  [Stress proteins: virulence factors of intracellular disease agents?].

Authors:  S H Kaufmann
Journal:  Immun Infekt       Date:  1989-08

9.  Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

Authors:  J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

10.  Molecular and immunological analysis of a polymorphic periplasmic protein of Borrelia burgdorferi.

Authors:  W J Simpson; M E Schrumpf; S F Hayes; T G Schwan
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

View more
  42 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Interlaboratory comparison of test results for detection of Lyme disease by 516 participants in the Wisconsin State Laboratory of Hygiene/College of American Pathologists Proficiency Testing Program.

Authors:  L L Bakken; S M Callister; P J Wand; R F Schell
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

3.  Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease.

Authors:  S Rauer; N Spohn; C Rasiah; U Neubert; A Vogt
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

4.  Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

Authors:  U Hauser; H Krahl; H Peters; V Fingerle; B Wilske
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

5.  Antibodies to Borrelia burgdorferi in European populations.

Authors:  J Gutiérrez; M Guerrero; F Nuñez; M J Soto; G Piédrola; M C Maroto
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

6.  Lyme borreliosis--an overdiagnosed disease?

Authors:  B Svenungsson; G Lindh
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

7.  Collection and characterization of samples for establishment of a serum repository for lyme disease diagnostic test development and evaluation.

Authors:  Claudia R Molins; Christopher Sexton; John W Young; Laura V Ashton; Ryan Pappert; Charles B Beard; Martin E Schriefer
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

8.  The Borrelia burgdorferi 37-kilodalton immunoblot band (P37) used in serodiagnosis of early lyme disease is the flaA gene product.

Authors:  R D Gilmore; R L Murphree; A M James; S A Sullivan; B J Johnson
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

9.  Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Authors:  B Wilske; V Fingerle; V Preac-Mursic; S Jauris-Heipke; A Hofmann; H Loy; H W Pfister; D Rössler; E Soutschek
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

10.  Novel Diagnosis of Lyme Disease: Potential for CAM Intervention.

Authors:  Aristo Vojdani; Frank Hebroni; Yaniv Raphael; Jonathan Erde; Bernard Raxlen
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-15       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.